T. Rowe Price Associates »

Cogent Biosciences shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $237k 35k 6.73
2023-12-31 $184k 31k 5.90
2023-09-30 $290k 30k 9.78
2023-06-30 $301k 25k 11.86
2023-03-31 $254k 24k 10.81
2022-12-31 $129k 11k 11.60

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Fiserv Comm Stk (FI)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Cogent Biosciences

Kynam Capital Management
FMR
BlackRock
Point72 Asset Management
Commodore Capital
Vanguard Group
VR Adviser
Fairmount Funds Management
Redmile Group
Millennium Management
Sofinnova Ventures
Vivo Capital
Henderson Group
Morgan Stanley
Geode Capital Management

View all funds holding Cogent Biosciences